.After antibody-drug conjugate (ADC) expert Seagen was marketed to Pfizer last year for a whopping $...
.On the heels of a stage 3 gain that fell short to impress entrepreneurs, Ironwood Pharmaceuticals i...
.Do not quit Monte Rosa Therapeutics right now. The Boston-based biotech is having a ball after auth...
.Accept to recently's Chutes & Ladders, our roundup of substantial leadership hirings, firings an...
.Celebrating his business's upsized initial public offering (IPO), Septerna chief executive officer ...
.AbbVie has gone back to the resource of its own antipsychotic powerhouse Vraylar trying to find an ...
.GenSight Biologics is weeks out of losing cash. Once again. The biotech merely has sufficient cash ...
.Monopar Therapeutics is bouncing back a drug coming from the scrap heap of AstraZeneca's rare condi...
.With brand new records out on Arcus Biosciences' experimental HIF-2a inhibitor, one team of experts...
.After creating a genetics therapy alliance along with Dyno Therapeutics in 2020, Roche is back for ...